What are the latest updates in colorectal cancer screening recommendations?

Latest Updates in Colorectal Cancer Screening

Key Change: Lowered Starting Age to 45 Years

The most significant recent update is that average-risk adults should now begin colorectal cancer screening at age 45 years, down from the previous recommendation of age 50. This change was driven by a concerning 51% increase in colorectal cancer incidence among adults younger than 55 years from 1994 to 2014 1.

Strength of Recommendation by Age Group

• Ages 45-49: The American Cancer Society provides a qualified recommendation to begin screening at age 45, while screening at age 50 remains a strong recommendation 1
• Ages 50-75: Strong recommendation for regular screening with high-quality evidence 1
• Ages 76-85: Individualize decisions based on patient preferences, life expectancy, health status, and prior screening history 1
• Over age 85: Discourage continued screening 1

The U.S. Preventive Services Task Force issued a Grade B recommendation for ages 45-49 and a Grade A recommendation for ages 50-75 1.

Screening Test Options: Tiered Approach

Tier 1 (First-Line Options)

The U.S. Multi-Society Task Force recommends a tiered system prioritizing:

• Colonoscopy every 10 years 1
• Annual fecal immunochemical test (FIT) 1

These are considered first-tier based on optimal effectiveness, cost-effectiveness, complete colon evaluation, and proven patient acceptance 1.

Tier 2 (If Colonoscopy and FIT Declined)

• CT colonography every 5 years 1
• Multitarget stool DNA (mt-sDNA) test every 3 years 1
• Flexible sigmoidoscopy every 5-10 years 1

Complete Menu of ACS-Approved Options

The American Cancer Society lists all acceptable screening modalities 1:

• Fecal immunochemical test (FIT) annually
• High-sensitivity guaiac-based fecal occult blood test annually
• Multitarget stool DNA test every 3 years
• Colonoscopy every 10 years
• CT colonography every 5 years
• Flexible sigmoidoscopy every 5 years

Critical caveat: All positive results on non-colonoscopy screening tests must be followed up with timely colonoscopy 1.

Quality Measures for Colonoscopy

Physicians performing screening colonoscopy must measure and report quality metrics, particularly the adenoma detection rate 1. The adenoma detection rate should be ≥25% overall, with adequate cecal intubation rates and appropriate withdrawal times 1.

Family History Modifications

High-Risk Individuals Require Earlier Screening

For individuals with a first-degree relative diagnosed before age 60 or two or more first-degree relatives at any age:

• Begin colonoscopy at age 40 or 10 years before the youngest affected relative's diagnosis, whichever comes first 1, 2
• Repeat colonoscopy every 5 years 1, 2

For individuals with a first-degree relative diagnosed at age 60 or older:

• Begin screening at age 40 using average-risk options (colonoscopy every 10 years or annual FIT) 1, 2

Special Populations

• Lynch syndrome: Colonoscopy every 3-5 years beginning 10 years before the youngest affected relative's diagnosis 1
• Inflammatory bowel disease: Begin colonoscopy 8-10 years after symptom onset with intervals based on disease extent and severity 1

Stopping Screening

Adults who are up to date with screening and have negative prior tests should consider stopping at age 75 or when life expectancy is less than 10 years 1. However, persons without prior screening may be considered for screening up to age 85, depending on age and comorbidities 1.

Common Pitfalls to Avoid

• Do not wait until age 50 for individuals with any first-degree relative with colorectal cancer—screening should begin at age 40 at the latest 2
• Verify family history details whenever possible, as this information is often incomplete or inaccurate and critically determines screening intensity 1, 2
• Do not use 10-year colonoscopy intervals if a first-degree relative was diagnosed before age 60 or if there are two or more affected first-degree relatives—these situations require 5-year intervals 2
• Ensure adequate follow-up of positive non-invasive tests with colonoscopy, as failure to complete diagnostic workup negates screening benefits 1

Emerging but Not Yet Recommended

Blood-based screening tests and other novel modalities (Septin9, capsule colonoscopy in most settings) are under investigation but are not currently recommended as first-line screening options 1, 3, 4. The U.S. Multi-Society Task Force suggests against Septin9 for colorectal cancer screening 1.